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httpcense.Abstract The current study aimed to investigate the possible beneﬁcial effects of grape seed extract
(GSE) on some metabolic and biochemical changes associated with streptozotocin (STZ; 50 mg/kg;
i.p.)-induced hyperglycaemia in male rats. Blood samples were used to determine serum levels of
glucose, insulin, total cholesterol (TC) and triglycerides (TG). Some biochemical markers for oxi-
dative stress viz., serum lipid peroxides level (measured as malondialdehyde; MDA) and total anti-
oxidant capacity as well as serum nitric oxide (NO) level were assessed. Hyperglycaemic animals
received GSE (100 and 300 mg/kg/day) orally on daily basis for 28 consecutive days and their effects
were determined 24 h after the administration of the last dose. Results of the present study revealed
that STZ-induced hyperglycaemia is associated with decreased serum insulin level with increased
levels of TC and TG. Hyperglycaemia was also associated with increased level of serum MDA
together with decreased total antioxidant capacity and level of serum NO. GSE succeeded to
improve the serum glucose level in STZ-treated rats in a dose dependent manner. It also showed
a restoration of the increased serum level of TC, TG and MDA and of the suppressed insulin
and total antioxidant capacity as well as the decreased plasma level of NO. From our results it
can be concluded that GSE has beneﬁcial effects against the biochemical changes associated with
STZ-induced hyperglycaemia. These beneﬁcial effects might be related to the ability of GSE to
improve hyperglycaemia in addition to its anti-oxidant property.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.Open access under CC BY-NC-ND license.1. Introduction
Diabetes mellitus (DM) is one of the most common chronic
diseases and is associated with some morbidities such as23152778.
.com (D.O. Saleh).
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://dx.doi.org/10.1016/j.bfopcu.2013obesity and hypertension.1,2 It is a progressive disease con-
stituting a complex syndrome involving insulin dysfunction
and is initially characterized by gross abnormalities in glu-
cose homoeostasis.3 DM is characterized by chronic hyper-
glycaemia resulting from defects in insulin secretion and/or
insulin action. The chronic hyperglycaemia of diabetes is
associated with long-term damage, dysfunction, and failure
of various organs, especially eyes, kidneys, nerves, heart,
and blood vessels.4
DM is amongst the silent killers, since many people are not
aware that they have the disease until they develop one of its
life-threatening complications.5 It well documented that DMaculty of Pharmacy, Cairo University.
.05.003
204 S.A. El-Awdan et al.not only contributes to the hyperglycaemia, but may play a
role in other metabolic abnormalities. These include high levels
of plasma triglycerides (TG), low levels of high density lipo-
proteins, hypertension, abnormal ﬁbrinolysis, and coronary
heart disease. This constellation of abnormalities is often re-
ferred to as the metabolic syndrome.6,7
There is considerable evidence that oxidative stress result-
ing from increased production and/or inadequate removal of
free radicals including reactive oxygen species (ROS) plays a
key role in the pathogenesis of late diabetic complications.8
It has been reported that in uncontrolled diabetes, the levels
of endogenous anti-oxidants such as superoxide dismutase,
vitamin E, and lipoic acid are markedly reduced. Enhanced
oxidative stress status arising from excess release of ROS has
been documented in diabetic animals and cells cultured under
high glucose conditions,9,10 and associated with the pathogen-
esis of diabetic endothelial dysfunction. ROS may be generated
as a result of prolonged exposure of cells to hyperglycaemia
that results in non-enzymatic glycation of plasma proteins11
which then undergo further spontaneous reactions to produce
free radicals such as superoxide anion, the foundation mole-
cule of other ROS.12
Superoxide anion is also formed by enzymatic activities
of cyclooxygenase, xanthine oxidase, uncoupled endothelial
nitric oxide synthase (eNOS) and NADPH oxidase.13
Amongst these enzymes NADPH oxidase enzyme system
has attracted much of the attention. It has been character-
ized as the main source of ROS in coronary microvascular
endothelial cells14 and has later been coupled to oxidative
stress-mediated endothelial dysfunction in the central retinas
of diabetic rats.15
Grape Seed Extract (GSE) are industrial derivatives from
whole grape seeds that have a great concentration of vitamin
E, ﬂavonoids, linoleic acid and phenolic oligo proanthocyani-
dins (also known as procyanidins), polymers of catechin.16
Proanthocyanidins were shown to have cardioprotection
against cardiac ischemia17 and have a role in lowering
cholesterol levels.18 However, many other beneﬁts of GSE pro-
anthocyanidins have also been uncovered including potent anti-
oxidant activity and cytotoxicity to cancer cells.17
The present study was devoted to investigate the inﬂuence
of grape seed extract (GSE) on some metabolic and biochem-
ical changes associated with hyperglycaemia in streptozotocin
(STZ)-treated rats. Gliclazide was also used as a reference
drug. Hyperglycaemia was induced by a single intraperitoneal
(i.p.) injection of streptozotocin. The extract was administered
orally once per day for 28 consecutive days and its effect was
evaluated 24 h after the administration of the last dose. For
the assessment of the metabolic changes, the serum levels of
glucose, insulin, total cholesterol (TC) and TG were deter-
mined. For the assessment of the biochemical changes, the
blood levels of some relevant biomarkers for oxidative stress
and NO were determined. Plasma lipid peroxides level (mea-
sured as malondialdehyde; MDA) and total antioxidant capac-
ity activity were taken as in vivo reliable indices for the
contribution of free radical generation and in turn, oxidative
stress in STZ-induced hyperglycaemia. Plasma nitrate/nitrite
level was used as a convenient marker for NO formation.
The effects produced by these treatments are compared with
the standard drug gliclazide.2. Materials and Methods
2.1. Drugs and chemicals
Grape seed extract (Mepaco, Egypt) and gliclazide (Servier,
Egypt) were used in the present investigation. The drugs were
freshly prepared in distilled water and given orally. The con-
centration of either drug was adjusted so that each 100 g ani-
mal body weight received 0.5 ml, containing the required
dose. Streptozotocin (STZ), N-(1-Naphthyl) ethylene-diamine
dihydrochloride (NEDD) were purchased from Sigma–Al-
drich, USA. Thiobarbituric acid (TBA) and Sulphanilamide
were purchased from Fluka (Italy) and Merck (Germany),
respectively. All other chemicals were of the highest commer-
cially available grade.
2.2. Animals
Adult male albino rats, weighing 180–200 g, were used in all
experiments of this study. They were obtained from the Ani-
mal House Colony of the National Research Center (Dokki,
Giza, Egypt), and were housed under conventional laboratory
conditions throughout the period of experimentation. The ani-
mals were fed standard rat pellet diet and allowed free access
to water. This study was conducted in accordance with ethical
procedures and policies approved by the Animal Care and Use
Committee of National Research Center.
2.3. Induction of hyperglycaemia
Hyperglycaemia was induced by a single i.p. injection of STZ
(50 mg/kg).19 Rats were weighed and injected with STZ dis-
solved in a citrate buffer (0.1 M, pH 4.5). After 48 h blood
samples were withdrawn from the retro-orbital venous plexus
under light ether anaesthesia and the serum was separated by
centrifugation for the determination of glucose level. Only rats
with serum glucose levels more than 250 mg/dl were selected
and considered as hyperglycaemic animals that have been sub-
jected to further experimentation.
2.4. Experimental design
Hyperglycaemic rats were weighed and randomly allocated
into four groups (8–10 rats each). One group served as a
hyperglycaemic control, another group was treated with gli-
clazide 5 mg/kg as a reference drug while the other two
groups were treated orally with GSE (100 mg/kg/day) and
GSE (300 mg/kg/day)20 for 28 consecutive days, respectively.
Drug treatment was started 48 h after STZ injection (time at
which hyperglycaemia was conﬁrmed). In addition, a univer-
sal normal group which received only the citrate buffer (8–10
rats) was used. Twenty-four hours after the last dose of either
drug treatment, serum was collected for the determination of
serum levels of insulin, TC, TG, MDA and NO levels as well
as total antioxidant capacity. Serum glucose level was mea-
sured thrice, the ﬁrst 48 h after STZ injection, the second
after 14 day treatment period and the third at the end of
the experiment.
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Figure 1 Effect of grape seed extract on serum glucose level in
streptozotocin-treated rats. Rats were rendered hyperglycaemic by
a single i.p. injection of streptozotocin (STZ; 50 mg/kg). Grape
seed extract (GSE; 100 mg/kg and 100 mg/kg; p.o.) was admin-
istered for 28 consecutive days. Treatment with either drug was
started 48 h after STZ injection. Blood samples from 18 h food-
deprived animals were withdrawn using heparinized capillary
tubes and serum was used for glucose determination 48 h after
STZ injection, after 14 consecutive days of treatment and twenty-
four hours after the last dose. Results are expressed as mean-
s ± SEM (n= 6–10). *Signiﬁcant difference from normal rats
P< 0.05. @ Signiﬁcant difference from hyperglycaemic rats
P< 0.05.
Grape seed extract attenuates hyperglycaemia-induced in rats by streptozotocin 2052.4.1. Assessment of metabolic and biochemical parameters
From each 18 h food-deprived rat, blood sample was with-
drawn from the retro-orbital venous plexus using heparin-
ized capillary tubes. The blood samples were centrifuged
at 3000 rpm for 10 min and the sera were obtained. An ali-
quot of the separated serum was then used for the determi-
nation of glucose level, TC and TG while the rest was
stored at 70 C for the subsequent determination of
insulin, MDA, NO levels and the total antioxidant
capacity.
2.4.2. Determination of serum glucose level
Glucose level was determined as quinine amine using a test re-
agent kit (Stanbio, USA) according to the method of Tinder
(1969).21 The absorbance was measured at 510 nm and the re-
sults were expressed as mg/dl.
2.4.3. Determination of serum insulin level
Serum insulin concentration was determined by enzyme-linked
immunosorbent assay by using a diagnostic kit (Crystalchem,
USA) according to the method of Judzewitsch et al. (1982).22
The absorbance was measured at 450 nm using ELISA reader
and the results were expressed as lIU/ml.
2.4.4. Determination of serum triglyceride level
Triglycerides were estimated by enzymatic methods by using
diagnostic kit (Biodiagnostic, Egypt) according to the
method of Fossati and Prencipe (1982).23 The absorbance
was measured at 510 nm and the results were expressed as
mg/dl.
2.4.5. Determination of serum total cholesterol level
Total cholesterol was estimated by enzymatic methods by
using diagnostic kit (Biodiagnostic, Egypt) according to the
method of Allain et al. (1974).24 The absorbance was measured
at 500 nm and the results were expressed as mg/dl.
2.4.6. Determination of serum lipid peroxide level
Lipid peroxide level was determined as thiobarbituric acid
(TBA)-reactive substances according to the method of Mihara
and Uchiyama (1978).25 The absorbance was measured at
534 nm and the results were expressed as nmol/ml.
2.4.7. Determination of serum nitric oxide level
The total amount of NO was indirectly estimated in terms of
its main metabolites, nitrate and nitrite by the Griess reaction
using NEDD and sulphanilamide as described by Miranda
et al. (2001).26 The absorbance was measured at 540 nm and
the results were expressed as nmol/ml.
2.4.8. Determination of total antioxidant capacity
Total antioxidant capacity was determined by ability to
eliminate a certain amount of the provided H2O2 using a
test reagent kit (Biodiagnostic, Egypt) according to the
method of Koracevic et al. (2001).27 The absorbance was
measured at 510 nm and the results were expressed as
mM/l.3. Statistical analysis
Data are expressed as means ± SEM. Statistical signiﬁcance
was taken as P< 0.05 for all experiments, using one way anal-
ysis of variance (ANOVA) followed by Tukey’s multiple com-
parison test to judge the difference between various groups for
the parametric parameters.
4. Results
4.1. Metabolic parameters
4.1.1. Effect of GSE on serum glucose level
A single i.p. injection of STZ (50 mg/kg) produced an elevation
of serum glucose level which was evidenced 48 h after admin-
istration. The elevation was found to be persistent during the
period of investigation and reached the average value of
409% of the normal ones. Oral treatment of hyperglycaemic
rats with GSE (100 mg/kg/day) and (300 mg/kg/day) for
2 weeks decreased the elevated serum glucose level reaching
about 194% and 174% of the normal values, respectively. Sim-
ilar treatment with gliclazide decreased the elevated serum glu-
cose level reaching about 190% of the normal value. Oral
treatment of hyperglycaemic rats with GSE 100 mg/kg/day
206 S.A. El-Awdan et al.and 300 mg/kg/day for 4 weeks succeeded to cause a decrease
in the elevated serum glucose level reaching about 144% and
119% of the normal values, respectively. Similar treatment
with gliclazide succeeded to cause a decrease in the elevated
serum glucose level reaching nearly the normal value (Fig. 1).
4.1.2. Effect of GSE on serum insulin level
Induction of hyperglycaemia with a single i.p. injection of STZ
(50 mg/kg) was associated with a decrease in the serum insulin
level. The decreased level reached about 6% of the normal va-
lue. Oral treatment of hyperglycaemic rats with GSE (100 mg/
kg/day) and (300 mg/kg/day) for 4 weeks caused an increase in
the serum insulin level reaching about 12% and 15% of the
normal values, respectively. Similar treatment with gliclazide
caused a decrease in the serum insulin level reaching about
40% of the normal value (Fig. 2).
4.1.3. Effect of GSE on serum TC level
Induction of hyperglycaemia with a single i.p. injection of STZ
(50 mg/kg) was associated with an increase in the serum TC le-
vel. The increased level reached about 170% of the normal va-
lue. Oral treatment of hyperglycaemic rats with GSE (100 mg/
kg/day) did not show any change in the serum TC level, how-
ever treatment with GSE (300 mg/kg/day) for 4 weeks showed
a decrease in the serum TC level reaching about 114% of the
normal value. Similar treatment with gliclazide succeeded to
cause a decrease in the elevated serum TC level reaching nearly
the normal value (Table 1).No
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Figure 2 Effect of grape seed extract on serum insulin level in
STZ-treated rats. Rats were rendered hyperglycaemic by a single
i.p. injection of streptozotocin (STZ; 50 mg/kg). Grape seed
extract (GSE; 100 mg/kg and 100 mg/kg; p.o.) were administered
for 28 consecutive days weeks. Treatment with either drug was
started 48 h after STZ injection. Twenty-four hours after the last
dose, blood samples from 18 h food-deprived animals were
withdrawn using heparinized capillary tubes and serum was used
for insulin determination. Results are expressed as means ± SEM
(n= 6–10). *Signiﬁcant difference from normal rats P< 0.05. @
Signiﬁcant difference from hyperglycaemic rats P< 0.05.4.1.4. Effect of GSE on serum TG level
Induction of hyperglycaemia with a single i.p. injection of STZ
(50 mg/kg) was associated with an increase in the serum TG le-
vel. The increased level reached about 260% of the normal va-
lue. Oral treatment of hyperglycaemic rats with GSE (100 mg/
kg/day) did not show any change in the serum TG level, how-
ever treatment with GSE (300 mg/kg/day) for 4 weeks showed
a decrease in the serum TG level reaching about 215% of the
normal value. Similar treatment with gliclazide succeeded to
cause a decrease in the elevated serum TC level reaching nearly
the normal value (Table 1).
4.1.5. Effect of GSE on serum MDA level
Induction of hyperglycaemia with a single i.p. injection of STZ
(50 mg/kg) was encountered with an elevated plasma MDA le-
vel. This elevation reached about 3-fold rise of the normal va-
lue. Oral treatment of hyperglycaemic rats with GSE 100 mg/
kg/day and 300 mg/kg/day for 4 weeks showed a decrease in
the serum MDA level reaching about 252% and 216% of
the normal values, respectively. Similar treatment with glicla-
zide succeeded to cause a decrease in the elevated serum
MDA level reaching nearly the normal value (Table 1).
4.1.6. Effect of GSE on serum NO level
Induction of hyperglycaemia with a single i.p. injection of STZ
(50 mg/kg) was accompanied with a decreased plasma NO le-
vel. This decrease reached about 44% of the normal value.
Oral treatment of hyperglycaemic rats with GSE 100 mg/kg/
day and 300 mg/kg/day for 4 weeks showed an increase in
the serum NO level reaching about 77% and 87% of the nor-
mal values, respectively. Similar treatment with gliclazide suc-
ceeded to cause a decrease in the elevated serum NO level
reaching about 81% of the normal value (Table 1).
4.1.7. Effect of GSE on serum total antioxidant capacity
Induction of hyperglycaemia with a single i.p. injection of STZ
(50 mg/kg) was accompanied with a decreased plasma NO le-
vel. This decrease reached about 39% of the normal value.
Oral treatment of hyperglycaemic rats with GSE 100 mg/kg/
day and 300 mg/kg/day for 4 weeks showed an increase in
the serum NO level reaching about 86% and 89% of the nor-
mal values, respectively. Similar treatment with gliclazide suc-
ceeded to cause a decrease in the elevated serum NO level
reaching about 88% of the normal value (Table 1).5. Discussion
Results of the present study revealed that STZ-induced hyper-
glycaemia is associated with some metabolic and biochemical
changes. Streptozotocin-induced hyperglycaemia in animals
is considered to be a potent model for the preliminary screen-
ing of compounds active against diabetes and is widely used.28
STZ, N-{methylnitrocarbamoyl}-d-glucosamine, is a potent
DNA methylating agent and acts as a NO donor in pancreatic
cells.29 It selectively destroys the islets of Langerhans by oxi-
dant production and producing inappropriate NO response.30
It has been shown that toxic action of STZ is due to the gen-
eration of free radicals31 which irreversibly destruct the b-islet
cells of the pancreas, causing degranulation or reduction of
insulin secretion. Low doses of STZ (50 mg/kg) only destroy
Table 1 Effect of grape seed extract on serum levels of triglycerides, total cholesterol, nitric oxide, malondialdehyde and total anti-
oxidant capacity in STZ-treated rats.
Normal Diabetic Glicazide GSE 100 mg/kg GSE 300 mg/kg
TC 72.67 ± 3.57 123.06 ± 9.33* 67.21 ± 2.10@ 123.06 ± 9.33* 82.95 ± 7.95@
TG 51.16 ± 2.40 133.12 ± 11.29* 49.92 ± 1.85@ 120.00 ± 11.04* 110.34 ± 6.57*@
NO 89.33 ± 4.90 38.94 ± 2.11* 72.23 ± 2.35*@ 68.61 ± 3.37*@ 77.87 ± 7.13*@
MDA 74.03 ± 3.26 216.98 ± 1.19* 86.64 ± 2.40@ 186.69 ± 17.82*@ 159.93 ± 9.59*@
Total antioxidant capacity 0.27 ± 0.019 0.16 ± 0.013* 0.36 ± 0.033*@ 0.34 ± 0.027*@ 0.35 ± 0.024@
Rats were rendered hyperglycaemic by a single i.p. injection of streptozotocin (STZ; 50 mg/kg). Grape seed extract (GSE; 100 mg/kg and
100 mg/kg; p.o.) was administered for 28 consecutive days weeks. Treatment with either drug was started 48 h after STZ injection. Twenty-four
hours after the last dose, blood samples from 18 h food-deprived animals were withdrawn using heparinized capillary tubes and serum was used
for determination of TG, TC, NO, MDA and total antioxidant capacity. Results are expressed as means ± SEM (n= 6–10).
* Signiﬁcant difference from normal rats P< 0.05.
@ Signiﬁcant difference from hyperglycaemic rats P< 0.05.
Grape seed extract attenuates hyperglycaemia-induced in rats by streptozotocin 207some population of pancreatic b-cells giving rise to type 2
DM.29
Persistent hyperglycaemia, the common characteristic of
DM, is the cause of the most diabetic complications which
can be normalized by the action of insulin.32 Blood glucose le-
vel is strictly controlled by insulin secretion from pancreatic
cells and insulin action on liver, muscle and other target
tissues.33
In the present study, oral treatment of STZ-treated rats
with GSE succeeded to lower the serum glucose levels proba-
bly partly due to its effect on insulin secretion and partly
due to its insulin sensitizer effect. This was in accordance with
Suwannaphet and his colleges who showed that GSE prevents
body weight gain, hyperglycaemia and hyperinsulinaemia due
to its ability to attenuate the impairment of insulin-stimulated
glucose disposal in rats with insulin resistance.34 Studies
showed that GSE strongly inhibited both a-amylase and a-glu-
cosidase activity, two key glucosidases required for starch
digestion in humans. It has been suggested that procyanidins
in GSE strongly inhibit a-amylase activity.35 Similar treatment
with gliclazide, a sulphonylurea antidiabetic drug succeeded to
cause a decrease in the elevated serum glucose level reaching
nearly the normal value is known to stimulate insulin secretion
from the pancreas.36
Hyperlipidaemia is a major characteristic of DM.37 DM in-
duced hyperlipidaemia is attributable to excess mobilization of
fat from the adipose tissue due to the under utilization of the
glucose.38 Moreover, studies suggested that hyperlipidemia is
one of the most common features in STZ-induced hyperglyca-
emia in experimental rats.39
In this study, an increase in the levels of TC and TG has
been observed in STZ-induced hyperglycaemic rats. Oral treat-
ment of hyperglycaemic rats with GSE (300 mg/kg) signiﬁ-
cantly decreased the serum levels of TC and TG. Hence, we
could say that GSE had beneﬁcial effects on carbohydrate
metabolism in hyperglycaemic rats. This antihyperlipidemic ef-
fect of GSE can be attributed to its ability to enhance the activ-
ity of enzymes involved in bile acid synthesis and its excretion
leading to a decrease in the serum TC and TG levels.40 This is
in accordance with other studies that showed that GSE pre-
vents body-weight gain.34 Procyanidin extract supplementa-
tion prevents high-fat diet-induced obesity in hamsters by
improving adipokine imbalance.41
Oxidative stress and overexpression of nitric oxide synthase
(NOS) have been discussed as interrelated contributing factorsin pancreatic b-cell dysfunction and destruction associated
with diabetic conditions that lead to micro- and macrovascular
complications. Hyperglycaemia is considered one of the fac-
tors responsible for the development of oxidative stress that re-
sults from enhanced formation of ROS by glucose
autooxidation.42 Hyperglycaemia may also play a role in the
decreased NO production in type 2 DM, because high glucose
per se inhibited endothelial NOS activity in the glomeruli,
through a protein kinase C associated mechanism.43 The de-
crease in production of NO during diabetic complications is
supposed to be the consequence of reduced production of
NO by NOS and inactivation of NO by ROS produced either
by glycosylated proteins or directly from vascular endothelium
as high level of HbA1c was observed in DM.44 Moreover, NO
is a key regulatory molecule with extensive metabolic, vascu-
lar, and cellular effects.45,46 The regulation of NO metabolism
is particularly important in type 2 DM.47,48
It was observed that the increase in the content of MDA
was signiﬁcant in animal models of DM and clinic diabetic suf-
ferer.49 The level of free radicals and lipid peroxidation in vivo
was associated with elevated blood sugar levels in patients.
When the free radicals increased, because of their special role
in cell toxicity, they may damage the body to produce a series
of roles, in which the pancreatic b cell damage is one of the
important factors that triggers DM and directly affects further
development of the disease.50
The present study provided a further evidence that STZ-in-
duced hyperglycaemia in rats is accompanied by increased lev-
els of MDA together with depleted levels of NO in the serum
concomitantly with suppression in the total antioxidant capac-
ity. It has been proven that induction of experimental hyper-
glycaemia with STZ results in enhanced lipid peroxidation.
Oxidative stress in DM coexists with a reduction in the antiox-
idant capacity, which can increase the deleterious effects of the
free radicals.51,52
Oral treatment of hyperglycaemic rats with GSE for 28 con-
secutive days succeeded to attenuate the lipid peroxidation as
it depleted the MDA levels, thus, decreasing the oxidative
stress. GSE helps to protect anti-oxidant enzymes. GSE signif-
icantly elevated the depleted NO levels by STZ. Many studies
have been reported that the monomers catechin and epicate-
chin (monomeric ﬂavanols) are the major phenolic compounds
in GSE that show its anti-oxidant activity. Catechin shows
antioxidant activity by inhibiting the oxidation of plasma
lipids. Moreover, epicatechin is able to scavenge hydroxyl
208 S.A. El-Awdan et al.radicals, peroxyl radicals, superoxide anion radicals.53 Procy-
anidins are reported to have potent antioxidant activity both
in vitro and in vivo.54
Moreover, previous studies attributed to the protective ef-
fect of GSE against cardiovascular events and atherosclerosis
and also to its ability to enhance eNOS expression and NO
production in hydrogen peroxide-treated human umbilical
vein endothelial cells in a dose-dependent manner.55
In conclusion, GSE supplementation has beneﬁcial and
protective effects against some metabolic and biochemical
changes associated with STZ-induced hyperglycaemia. These
effects might be related to the ability of GSE to improve hyper-
glycaemia in addition to its anti-oxidant property.6. Conﬂict of interest
None.
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